Home > Publications Database > The frequency of non-motor symptoms in SCA3 and their association with disease severity and lifestyle factors. > print

001     165522
005     20231120155327.0
024 7 _ |a pmc:PMC9886646
|2 pmc
024 7 _ |a 10.1007/s00415-022-11441-z
|2 doi
024 7 _ |a pmid:36324033
|2 pmid
024 7 _ |a 0012-1037
|2 ISSN
024 7 _ |a 0340-5354
|2 ISSN
024 7 _ |a 0939-1517
|2 ISSN
024 7 _ |a 1432-1459
|2 ISSN
024 7 _ |a 1619-800X
|2 ISSN
024 7 _ |a altmetric:138172711
|2 altmetric
024 7 _ |a 0367-004x
|2 ISSN
024 7 _ |a 0367-004X
|2 ISSN
037 _ _ |a DZNE-2022-01668
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Hengel, Holger
|0 P:(DE-2719)2811940
|b 0
|e First author
|u dzne
245 _ _ |a The frequency of non-motor symptoms in SCA3 and their association with disease severity and lifestyle factors.
260 _ _ |a Berlin
|c 2023
|b Springer
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1676383031_8740
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a ISSN 1432-1459 not unique: **2 hits**.
520 _ _ |a Non-motor symptoms (NMS) are a substantial burden for patients with SCA3. There are limited data on their frequency, and their relation with disease severity and activities of daily living is not clear. In addition, lifestyle may either influence or be affected by the occurrence of NMS.To characterize NMS in SCA3 and investigate possible associations with disease severity and lifestyle factors.In a prospective cohort study, we performed a cross-sectional analysis of NMS in 227 SCA3 patients, 42 pre-ataxic mutation carriers, and 112 controls and tested for associations with SARA score, activities of daily living, and the lifestyle factors alcohol consumption, smoking and physical activity.Sleep disturbance, restless legs syndrome, mild cognitive impairment, depression, bladder dysfunction and pallhypesthesia were frequent among SCA3 patients, while mainly absent in pre-ataxic mutation carriers. Except for restless legs syndrome, NMS correlated significantly with disease severity and activities of daily living. Alcohol abstinence was associated with bladder dysfunction. Patients with higher physical activity showed less cognitive impairment and fewer depressive symptoms, but these differences were not significant.This study revealed a clear association between disease severity and NMS, likely driven by the progression of the widespread neurodegenerative process. Associations between lifestyle and NMS can probably be attributed to the influence of NMS on lifestyle.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
542 _ _ |i 2022-11-02
|2 Crossref
|u https://creativecommons.org/licenses/by/4.0
542 _ _ |i 2022-11-02
|2 Crossref
|u https://creativecommons.org/licenses/by/4.0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Lifestyle
|2 Other
650 _ 7 |a Non-motor symptoms
|2 Other
650 _ 7 |a Physical activity
|2 Other
650 _ 7 |a SCA3
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Restless Legs Syndrome: epidemiology
|2 MeSH
650 _ 2 |a Prospective Studies
|2 MeSH
650 _ 2 |a Cross-Sectional Studies
|2 MeSH
650 _ 2 |a Activities of Daily Living
|2 MeSH
650 _ 2 |a Patient Acuity
|2 MeSH
650 _ 2 |a Life Style
|2 MeSH
700 1 _ |a Martus, Peter
|b 1
700 1 _ |a Faber, Jennifer
|0 P:(DE-2719)2811327
|b 2
|u dzne
700 1 _ |a Giunit, Paola
|b 3
700 1 _ |a Garcia-Moreno, Hector
|b 4
700 1 _ |a Solanky, Nita
|b 5
700 1 _ |a Klockgether, Thomas
|0 P:(DE-2719)2810314
|b 6
|u dzne
700 1 _ |a Reetz, Kathrin
|b 7
700 1 _ |a van de Warrenburg, Bart P
|b 8
700 1 _ |a Santana, Magda M
|b 9
700 1 _ |a Silva, Patrick
|b 10
700 1 _ |a Cunha, Maria Ines
|0 P:(DE-2719)2811784
|b 11
|u dzne
700 1 _ |a de Almeida, Luís Pereira
|b 12
700 1 _ |a Timmann, Dagmar
|b 13
700 1 _ |a Infante, Jon
|b 14
700 1 _ |a de Vries, Jeroen
|b 15
700 1 _ |a Lima, Manuela
|b 16
700 1 _ |a Pires, Paula
|b 17
700 1 _ |a Bushara, Khalaf
|b 18
700 1 _ |a Jacobi, Heike
|0 P:(DE-2719)2811564
|b 19
|u dzne
700 1 _ |a Onyike, Chiadi
|b 20
700 1 _ |a Schmahmann, Jeremy D
|b 21
700 1 _ |a Hübener-Schmid, Jeannette
|b 22
700 1 _ |a Synofzik, Matthis
|0 P:(DE-2719)2811275
|b 23
|u dzne
700 1 _ |a Initiative, European Spinocerebellar Ataxia Type-3/Machado-Joseph Disease
|b 24
|e Collaboration Author
700 1 _ |a Schöls, Ludger
|0 P:(DE-2719)2810795
|b 25
|e Last author
|u dzne
773 1 8 |a 10.1007/s00415-022-11441-z
|b Springer Science and Business Media LLC
|d 2022-11-02
|n 2
|p 944-952
|3 journal-article
|2 Crossref
|t Journal of Neurology
|v 270
|y 2022
|x 0340-5354
773 _ _ |a 10.1007/s00415-022-11441-z
|0 PERI:(DE-600)1421299-7
|n 2
|p 944-952
|t Journal of neurology
|v 270
|y 2022
|x 0340-5354
856 4 _ |u https://pub.dzne.de/record/165522/files/DZNE-2022-01668%20SUP.odp
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/165522/files/DZNE-2022-01668%20SUP.pdf
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/165522/files/DZNE-2022-01668%20SUP.ppt
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/165522/files/DZNE-2022-01668%20SUP.pptx
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/165522/files/DZNE-2022-01668.pdf
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/165522/files/DZNE-2022-01668.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:pub.dzne.de:165522
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2811940
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)2811327
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-2719)2810314
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 11
|6 P:(DE-2719)2811784
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 19
|6 P:(DE-2719)2811564
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 23
|6 P:(DE-2719)2811275
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 25
|6 P:(DE-2719)2810795
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2022
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-10-21
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-21
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J NEUROL : 2022
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-21
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-10-21
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b J NEUROL : 2022
|d 2023-10-21
920 1 _ |0 I:(DE-2719)5000005
|k AG Schöls
|l Clinical Neurogenetics
|x 0
920 1 _ |0 I:(DE-2719)1210000
|k AG Gasser 1
|l Parkinson Genetics
|x 1
920 1 _ |0 I:(DE-2719)1011101
|k Patient studies, Bonn
|l Patient studies
|x 2
920 1 _ |0 I:(DE-2719)1011001
|k AG Klockgether
|l Clinical Research- coordination
|x 3
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1210000-6
980 _ _ |a I:(DE-2719)1210000
980 _ _ |a I:(DE-2719)1011101
980 _ _ |a I:(DE-2719)1011001
980 _ _ |a UNRESTRICTED
980 1 _ |a FullTexts
999 C 5 |a 10.1089/ars.2020.8075
|9 -- missing cx lookup --
|1 I Marques-Aleixo
|p 674 -
|2 Crossref
|u Marques-Aleixo I et al (2021) Preventive and therapeutic potential of physical exercise in neurodegenerative diseases. Antioxid Redox Signal 34:674–693
|t Antioxid Redox Signal
|v 34
|y 2021
999 C 5 |a 10.1016/j.sleep.2014.03.025
|9 -- missing cx lookup --
|1 RP Allen
|p 860 -
|2 Crossref
|u Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW, Zucconi M, Ferri R, Trenkwalder C, Lee HB (2014) Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria–history, rationale, description, and significance. Sleep Med 15:860–873
|t Sleep Med
|v 15
|y 2014
999 C 5 |a 10.1016/bs.irn.2015.07.004
|9 -- missing cx lookup --
|1 J Audrain-McGovern
|p 209 -
|2 Crossref
|u Audrain-McGovern J, Leventhal AM, Strong DR (2015) The role of depression in the uptake and maintenance of cigarette smoking. Int Rev Neurobiol 124:209–243
|t Int Rev Neurobiol
|v 124
|y 2015
999 C 5 |a 10.1136/bjsports-2020-102955
|9 -- missing cx lookup --
|1 FC Bull
|p 1451 -
|2 Crossref
|u Bull FC, Al-Ansari SS, Biddle S, Borodulin K, Buman MP, Cardon G, Carty C, Chaput J-P, Chastin S, Chou R, Dempsey PC, DiPietro L, Ekelund U, Firth J, Friedenreich CM, Garcia L, Gichu M, Jago R, Katzmarzyk PT, Lambert E, Leitzmann M, Milton K, Ortega FB, Ranasinghe C, Stamatakis E, Tiedemann A, Troiano RP, van der Ploeg HP, Wari V, Willumsen JF (2020) World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med 54:1451
|t Br J Sports Med
|v 54
|y 2020
999 C 5 |a 10.1016/0165-1781(89)90047-4
|9 -- missing cx lookup --
|1 DJ Buysse
|p 193 -
|2 Crossref
|u Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213
|t Psychiatry Res
|v 28
|y 1989
999 C 5 |a 10.1249/01.MSS.0000078924.61453.FB
|9 -- missing cx lookup --
|1 CL Craig
|p 1381 -
|2 Crossref
|u Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35:1381–1395
|t Med Sci Sports Exerc
|v 35
|y 2003
999 C 5 |a 10.1111/j.1600-0404.2008.01092.x
|9 -- missing cx lookup --
|1 A D'Abreu
|p 277 -
|2 Crossref
|u D’Abreu A, França M Jr, Conz L, Friedman JH, Nucci AM, Cendes F, Lopes-Cendes I (2009) Sleep symptoms and their clinical correlates in Machado-Joseph disease. Acta Neurol Scand 119:277–280
|t Acta Neurol Scand
|v 119
|y 2009
999 C 5 |a 10.1002/mds.22288
|9 -- missing cx lookup --
|1 C Globas
|p 2232 -
|2 Crossref
|u Globas C, du Montcel ST, Baliko L, Boesch S, Depondt C, DiDonato S, Durr A, Filla A, Klockgether T, Mariotti C, Melegh B, Rakowicz M, Ribai P, Rola R, Schmitz-Hubsch T, Szymanski S, Timmann D, Van de Warrenburg BP, Bauer P, Schols L (2008) Early symptoms in spinocerebellar ataxia type 1, 2, 3, and 6. Mov Disorders 23:2232–2238
|t Mov Disorders
|v 23
|y 2008
999 C 5 |a 10.1002/mds.28844
|9 -- missing cx lookup --
|1 H Hengel
|p 405 -
|2 Crossref
|u Hengel H, Martus P, Faber J, Garcia-Moreno H, Solanky N, Giunti P, Klockgether T, Reetz K, van de Warrenburg BP, Pereira de Almeida L, Santana MM, Januario C, Silva P, Thieme A, Infante J, de Vries J, Lima M, Ferreira AF, Bushara K, Jacobi H, Onyike C, Schmahmann JD, Hubener-Schmid J, Synofzik M, Schols L (2022) Characterization of lifestyle in spinocerebellar ataxia type 3 and Association with Disease Severity. Mov Disorders 37:405–410
|t Mov Disorders
|v 37
|y 2022
999 C 5 |a 10.1186/s12889-020-09323-y
|9 -- missing cx lookup --
|1 MX Hu
|p 1255 -
|2 Crossref
|u Hu MX, Turner D, Generaal E, Bos D, Ikram MK, Ikram MA, Cuijpers P, Penninx BWJH (2020) Exercise interventions for the prevention of depression: a systematic review of meta-analyses. BMC Public Health 20:1255
|t BMC Public Health
|v 20
|y 2020
999 C 5 |a 10.1016/j.ehj.2004.09.032
|9 -- missing cx lookup --
|1 A Imhof
|p 2092 -
|2 Crossref
|u Imhof A, Woodward M, Doering A, Helbecque N, Loewel H, Amouyel P, Lowe GD, Koenig W (2004) Overall alcohol intake, beer, wine, and systemic markers of inflammation in western Europe: results from three MONICA samples (Augsburg, Glasgow, Lille). Eur Heart J 25:2092–2100
|t Eur Heart J
|v 25
|y 2004
999 C 5 |a 10.1007/s12311-012-0421-3
|9 -- missing cx lookup --
|1 H Jacobi
|p 418 -
|2 Crossref
|u Jacobi H, Rakowicz M, Rola R, Fancellu R, Mariotti C, Charles P, Dürr A, Küper M, Timmann D, Linnemann C, Schöls L, Kaut O, Schaub C, Filla A, Baliko L, Melegh B, Kang JS, Giunti P, van de Warrenburg BP, Fimmers R, Klockgether T (2013) Inventory of Non-Ataxia Signs (INAS): validation of a new clinical assessment instrument. Cerebellum 12:418–428
|t Cerebellum
|v 12
|y 2013
999 C 5 |a 10.1007/s12311-020-01126-6
|9 -- missing cx lookup --
|1 M Jang
|p 483 -
|2 Crossref
|u Jang M, Kim HJ, Kim A, Jeon B (2020) Urinary symptoms and urodynamic findings in patients with spinocerebellar Ataxia. Cerebellum 19:483–486
|t Cerebellum
|v 19
|y 2020
999 C 5 |a 10.1002/ajmg.b.30265
|9 -- missing cx lookup --
|1 M Konieczny
|p 173 -
|2 Crossref
|u Konieczny M, Bauer P, Tomiuk J, Weisser G, Haan J, Berger K, Riess O, Schöls L (2006) CAG repeats in restless legs syndrome. Am J Med Genet B 141:173–176
|t Am J Med Genet B
|v 141
|y 2006
999 C 5 |a 10.1046/j.1525-1497.2001.016009606.x
|9 -- missing cx lookup --
|1 K Kroenke
|p 606 -
|2 Crossref
|u Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16:606–613
|t J Gen Intern Med
|v 16
|y 2001
999 C 5 |a 10.1007/s12311-015-0684-6
|9 -- missing cx lookup --
|1 C Linnemann
|p 165 -
|2 Crossref
|u Linnemann C, Tezenas du Montcel S, Rakowicz M, Schmitz-Hübsch T, Szymanski S, Berciano J, van de Warrenburg BP, Pedersen K, Depondt C, Rola R, Klockgether T, García A, Mutlu G, Schöls L (2016) Peripheral neuropathy in spinocerebellar Ataxia type 1, 2, 3, and 6. Cerebellum 15:165–173
|t Cerebellum
|v 15
|y 2016
999 C 5 |a 10.1016/S0140-6736(20)30367-6
|9 -- missing cx lookup --
|1 G Livingston
|p 413 -
|2 Crossref
|u Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Brayne C, Burns A, Cohen-Mansfield J, Cooper C, Costafreda SG, Dias A, Fox N, Gitlin LN, Howard R, Kales HC, Kivimäki M, Larson EB, Ogunniyi A, Orgeta V, Ritchie K, Rockwood K, Sampson EL, Samus Q, Schneider LS, Selbæk G, Teri L, Mukadam N (2020) Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 396:413–446
|t Lancet
|v 396
|y 2020
999 C 5 |a 10.1089/ars.2020.8075
|9 -- missing cx lookup --
|1 I Marques-Aleixo
|p 674 -
|2 Crossref
|u Marques-Aleixo I, Beleza J, Sampaio A, Stevanović J, Coxito P, Gonçalves I, Ascensão A, Magalhães J (2021) Preventive and therapeutic potential of physical exercise in neurodegenerative diseases. Antioxid Redox Signal 34:674–693
|t Antioxid Redox Signal
|v 34
|y 2021
999 C 5 |a 10.1007/s00415-010-5810-2
|9 -- missing cx lookup --
|1 AF Musegante
|p 623 -
|2 Crossref
|u Musegante AF, Almeida PN, Barboza AL, Barroso U Jr (2011) Urinary symptoms and urodynamic findings in patients with Machado-Joseph disease. J Neurol 258:623–626
|t J Neurol
|v 258
|y 2011
999 C 5 |a 10.1111/j.1532-5415.2005.53221.x
|9 -- missing cx lookup --
|1 ZS Nasreddine
|p 695 -
|2 Crossref
|u Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699
|t J Am Geriatr Soc
|v 53
|y 2005
999 C 5 |a 10.1590/S0004-282X2011000200021
|9 -- missing cx lookup --
|1 JL Pedroso
|p 253 -
|2 Crossref
|u Pedroso JL, Braga-Neto P, Felício AC, Aquino CC, Prado LB, Prado GF, Barsottini OG (2011) Sleep disorders in cerebellar ataxias. Arq Neuropsiquiatr 69:253–257
|t Arq Neuropsiquiatr
|v 69
|y 2011
999 C 5 |a 10.1002/mds.25513
|9 -- missing cx lookup --
|1 JL Pedroso
|p 1200 -
|2 Crossref
|u Pedroso JL, França MC Jr, Braga-Neto P, D’Abreu A, Saraiva-Pereira ML, Saute JA, Teive HA, Caramelli P, Jardim LB, Lopes-Cendes I, Barsottini OG (2013) Nonmotor and extracerebellar features in Machado-Joseph disease: a review. Mov Disorders 28:1200–1208
|t Mov Disorders
|v 28
|y 2013
999 C 5 |a 10.1016/S1474-4422(16)30287-3
|9 -- missing cx lookup --
|1 K Reetz
|p 1346 -
|2 Crossref
|u Reetz K, Dogan I, Hilgers R-D, Giunti P, Mariotti C, Durr A, Boesch S, Klopstock T, de Rivera FJR, Schöls L, Klockgether T, Bürk K, Rai M, Pandolfo M, Schulz JB, Nachbauer W, Eigentler A, Depondt C, Benaich S, Charles P, Ewenczyk C, Monin M-L, Dafotakis M, Fedosov K, Didszun C, Ermis U, Giordano IA, Timmann D, Karin I, Neuhofer C, Stendel C, Müller vom Hagen J, Wolf J, Panzeri M, Nanetti L, Castaldo A, Arpa J, Sanz-Gallego I, Parkinson MH, Sweeney MG (2016) Progression characteristics of the European Friedreich’s Ataxia Consortium for Translational Studies (EFACTS): a 2 year cohort study. Lancet Neurol 15:1346–1354
|t Lancet Neurol
|v 15
|y 2016
999 C 5 |a 10.1097/WCO.0b013e3282f7673d
|9 -- missing cx lookup --
|1 U Rüb
|p 111 -
|2 Crossref
|u Rüb U, Brunt ER, Deller T (2008) New insights into the pathoanatomy of spinocerebellar ataxia type 3 (Machado-Joseph disease). Curr Opin Neurol 21:111–116
|t Curr Opin Neurol
|v 21
|y 2008
999 C 5 |a 10.1016/j.pneurobio.2013.01.001
|9 -- missing cx lookup --
|1 U Rüb
|p 38 -
|2 Crossref
|u Rüb U, Schöls L, Paulson H, Auburger G, Kermer P, Jen JC, Seidel K, Korf HW, Deller T (2013) Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7. Prog Neurobiol 104:38–66
|t Prog Neurobiol
|v 104
|y 2013
999 C 5 |a 10.1093/brain/awh729
|9 -- missing cx lookup --
|1 JD Schmahmann
|p 290 -
|2 Crossref
|u Schmahmann JD, Caplan D (2006) Cognition, emotion and the cerebellum. Brain 129:290–292
|t Brain
|v 129
|y 2006
999 C 5 |a 10.1212/01.wnl.0000325057.33666.72
|9 -- missing cx lookup --
|1 T Schmitz-Hübsch
|p 982 -
|2 Crossref
|u Schmitz-Hübsch T, Coudert M, Bauer P, Giunti P, Globas C, Baliko L, Filla A, Mariotti C, Rakowicz M, Charles P, Ribai P, Szymanski S, Infante J, van de Warrenburg BP, Dürr A, Timmann D, Boesch S, Fancellu R, Rola R, Depondt C, Schöls L, Zdienicka E, Kang JS, Döhlinger S, Kremer B, Stephenson DA, Melegh B, Pandolfo M, di Donato S, du Montcel ST, Klockgether T (2008) Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. Neurology 71:982–989
|t Neurology
|v 71
|y 2008
999 C 5 |a 10.1002/mds.23698
|9 -- missing cx lookup --
|1 T Schmitz-Hübsch
|p 870 -
|2 Crossref
|u Schmitz-Hübsch T, Coudert M, Tezenas du Montcel S, Giunti P, Labrum R, Dürr A, Ribai P, Charles P, Linnemann C, Schöls L, Rakowicz M, Rola R, Zdzienicka E, Fancellu R, Mariotti C, Baliko L, Melegh B, Filla A, Salvatore E, van de Warrenburg BP, Szymanski S, Infante J, Timmann D, Boesch S, Depondt C, Kang JS, Schulz JB, Klopstock T, Lossnitzer N, Löwe B, Frick C, Rottländer D, Schlaepfer TE, Klockgether T (2011) Depression comorbidity in spinocerebellar ataxia. Mov Disorders 26:870–876
|t Mov Disorders
|v 26
|y 2011
999 C 5 |a 10.1212/01.wnl.0000219042.60538.92
|9 -- missing cx lookup --
|1 T Schmitz-Hübsch
|p 1717 -
|2 Crossref
|u Schmitz-Hübsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, Giunti P, Globas C, Infante J, Kang JS, Kremer B, Mariotti C, Melegh B, Pandolfo M, Rakowicz M, Ribai P, Rola R, Schöls L, Szymanski S, van de Warrenburg BP, Dürr A, Klockgether T, Fancellu R (2006) Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 66:1717–1720
|t Neurology
|v 66
|y 2006
999 C 5 |a 10.1136/jnnp.61.5.466
|9 -- missing cx lookup --
|1 L Schöls
|p 466 -
|2 Crossref
|u Schöls L, Amoiridis G, Epplen JT, Langkafel M, Przuntek H, Riess O (1996) Relations between genotype and phenotype in German patients with the Machado-Joseph disease mutation. J Neurol Neurosurg Psychiatry 61:466–470
|t J Neurol Neurosurg Psychiatry
|v 61
|y 1996
999 C 5 |a 10.1176/appi.ajp.2018.17111194
|9 -- missing cx lookup --
|1 FB Schuch
|p 631 -
|2 Crossref
|u Schuch FB, Vancampfort D, Firth J, Rosenbaum S, Ward PB, Silva ES, Hallgren M, Ponce De Leon A, Dunn AL, Deslandes AC, Fleck MP, Carvalho AF, Stubbs B (2018) Physical activity and incident depression: a meta-analysis of prospective cohort studies. Am J Psychiatry 175:631–648
|t Am J Psychiatry
|v 175
|y 2018
999 C 5 |a 10.3389/fneur.2020.00266
|9 -- missing cx lookup --
|1 JS Yang
|p 266 -
|2 Crossref
|u Yang JS, Xu HL, Chen PP, Sikandar A, Qian MZ, Lin HX, Lin MT, Chen WJ, Wang N, Wu H, Gan SR (2020) Ataxic severity is positively correlated with fatigue in spinocerebellar Ataxia type 3 patients. Front Neurol 11:266
|t Front Neurol
|v 11
|y 2020
999 C 5 |a 10.1002/mds.10033
|9 -- missing cx lookup --
|1 TM Zawacki
|p 1004 -
|2 Crossref
|u Zawacki TM, Grace J, Friedman JH, Sudarsky L (2002) Executive and emotional dysfunction in Machado-Joseph disease. Mov Disorders 17:1004–1010
|t Mov Disorders
|v 17
|y 2002

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21